Omolaoye Temidayo S, Velilla Paula A, Moncada López Juan Sebastián, du Plessis Stefan S, Cardona Maya Walter D
Department of Basic Sciences, College of Medicine, Mohammed Bin Rashid University of Medicine and Health Sciences, 505055 Dubai, United Arab Emirates.
Immunovirology Group, Department of Microbiology and Parasitology, Faculty of Medicine, University of Antioquia-UdeA, 050010 Medellín, Colombia.
Arch Esp Urol. 2022 Dec;75(10):831-843. doi: 10.56434/j.arch.esp.urol.20227510.121.
Vaccination against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) epitomizes the best preventative SARS-CoV-2 infection strategy to counteract the severe consequences of infection. However, concerns have been raised that the vaccines could have an adverse effect on sperm function and overall reproductive health. This combined systematic review and meta-analysis aimed to investigate the effects of different available SARS-CoV-2 vaccines on semen parameters.
A systematic PubMed, Scopus, Google Scholar, ScienceDirect, LILACS (Literatura Latinoamericana y del Caribe en Ciencias de la Salud), and Scilit database literature search until mid-June 2022 was conducted. Prospective and retrospective studies were eligible. No limitation was placed on language. Standardized mean differences (SMDs) with 95% confidence intervals (CIs) were thereafter obtained.
Upon search completion, 122 studies were identified and retrieved and 110 were excluded, while the remaining 12 independent studies evaluating the effects of coronavirus disease 2019 (COVID-19) vaccines on semen parameters were included in this review. The total number of men included was 1551, aged 22.4-48 years. Following meta-analysis, the SMD summary measure with 95% CI for each semen parameter included a concentration of 0.22 (0-0.22); Total sperm count of 0.11 (0.18-0.24); Total motility of 0.02 (0.05-0.09); Volume of 0.02 (-0.1-0.14); Vitality of 0.55 (-0.19-0.29), progressive motility of -0.43 (-0.54 to -0.32); Total motile sperm count of -0.38 (-0.44 to -0.31); And normal morphology of 0.42 (-0.54 to -0.3). In brief, the total sperm count was slightly increased post-vaccination, while progressive motility, total motile sperm count, and normal morphology were marginally reduced post-vaccination, according to the meta-analysis.
No effects were observed regarding sperm viability and semen volume since the results of all the studies crossed the line of no effect. All seminal parameters analyzed showed a negligible or small change in relation to the vaccination effect. Furthermore, the parameters remained within the normal World Health Organization reference ranges, making the clinical significance unclear. Therefore, based on these results, it appears that vaccination does not have negative effects on semen quality. The individual study findings suggested that COVID-19 vaccines are not associated with decreased semen parameters.
接种严重急性呼吸综合征冠状病毒2(SARS-CoV-2)疫苗是对抗SARS-CoV-2感染严重后果的最佳预防策略。然而,有人担心这些疫苗可能会对精子功能和整体生殖健康产生不利影响。本系统评价与荟萃分析旨在研究不同的可用SARS-CoV-2疫苗对精液参数的影响。
对PubMed、Scopus、谷歌学术、ScienceDirect、拉丁美洲和加勒比卫生科学文献数据库(LILACS)以及Scilit数据库进行系统的文献检索,直至2022年6月中旬。前瞻性和回顾性研究均符合要求。语言不限。此后获得了具有95%置信区间(CI)的标准化均值差(SMD)。
检索完成后,共识别并检索到122项研究,排除110项,其余12项评估2019冠状病毒病(COVID-19)疫苗对精液参数影响的独立研究纳入本综述。纳入的男性总数为1551人,年龄在22.4至48岁之间。荟萃分析后,每个精液参数的95%CI的SMD汇总测量值包括浓度为0.22(0 - 0.22);总精子数为0.11(0.18 - 0.24);总活力为0.02(0.05 - 0.09);体积为0.02(-0.1 - 0.14);活力为0.55(-0.19 - 0.29),前向运动率为-0.43(-0.54至-0.32);总活动精子数为-0.38(-0.44至-0.31);正常形态为0.42(-0.54至-0.3)。简而言之,根据荟萃分析,接种疫苗后总精子数略有增加,而接种疫苗后前向运动率、总活动精子数和正常形态略有下降。
由于所有研究结果均未越过无效应线,因此未观察到对精子活力和精液体积的影响。所有分析的精液参数与疫苗接种效果相比显示出可忽略不计或微小的变化。此外,这些参数仍在世界卫生组织正常参考范围内,临床意义尚不清楚。因此,基于这些结果,接种疫苗似乎对精液质量没有负面影响。个别研究结果表明,COVID-19疫苗与精液参数降低无关。